No alteration of voriconazole concentration by plasmapheresis in a critically ill patient
- 22 October 2018
- journal article
- letter
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 75 (2) , 287-288
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2016
- Protein-Binding Characteristics of Voriconazole Determined by High-Throughput Equilibrium DialysisJournal of Pharmaceutical Sciences, 2014
- How to manage aspergillosis in non-neutropenic intensive care unit patientsCritical Care, 2014
- Pharmacokinetic Profile of Voriconazole in a Critically Ill Patient on Therapeutic Plasma ExchangeTherapeutic Drug Monitoring, 2013
- Challenging Recommended Oral and Intravenous Voriconazole Doses for Improved Efficacy and Safety: Population Pharmacokinetics–Based Analysis of Adult Patients With Invasive Fungal InfectionsClinical Infectious Diseases, 2012
- Drug Removal by Plasmapheresis: An Evidence‐Based ReviewPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2007
- Pharmacokinetic/Pharmacodynamic Profile of VoriconazoleClinical Pharmacokinetics, 2006
- Extracorporeal removal of antimicrobials during plasmapheresisJournal of Clinical Apheresis, 2003